Sensus Healthcare director buys 1,500 company shares

Sensus Healthcare director Eric Sachetta reported an open-market purchase of company stock.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Sensus Healthcare director Eric Sachetta reported an open-market purchase of company stock. On May 12, 2026, he bought 1,500 shares of Sensus Healthcare, Inc. common stock at $3.335 per share.

Following this transaction, he directly holds 143,613 common shares and also reports indirect ownership of 2,093 shares held by his spouse.

Insider Trade Summary

Net Buyer: 1,500 shares

Net Buy 2 txns

Insider Sachetta Eric

Role Director

Bought 1,500 shs ($5K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	1,500	$3.335	$5K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 143,613 shares (Direct); Common Stock — 2,093 shares (Indirect, spouse)

Key Figures

Shares purchased: 1,500 shares Purchase price: $3.335 per share Direct holdings after transaction: 143,613 shares +1 more

4 metrics

Shares purchased 1,500 shares Open-market buy on May 12, 2026

Purchase price $3.335 per share Common Stock, open-market transaction

Direct holdings after transaction 143,613 shares Common Stock owned directly after purchase

Indirect holdings 2,093 shares Common Stock held indirectly via spouse

Key Terms

open-market purchase, indirect ownership, Common Stock

3 terms

open-market purchase financial

"he bought 1,500 shares of Sensus Healthcare, Inc. common stock at $3.335 per share"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

indirect ownership financial

"also reports indirect ownership of 2,093 shares held by his spouse"

Common Stock financial

"bought 1,500 shares of Sensus Healthcare, Inc. common stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Sensus Healthcare (SRTS) report for Eric Sachetta?

Sensus Healthcare reported that director Eric Sachetta bought 1,500 shares of common stock in an open-market transaction. This purchase was made at a price of $3.335 per share, increasing his directly owned stake in the company.

How many Sensus Healthcare (SRTS) shares did Eric Sachetta buy and at what price?

Eric Sachetta bought 1,500 Sensus Healthcare common shares at $3.335 each. This open-market purchase adds to his existing holdings and reflects a modest increase in his direct ownership position in the company’s stock.

What are Eric Sachetta’s total direct Sensus Healthcare (SRTS) holdings after this Form 4?

After the reported transaction, Eric Sachetta directly owns 143,613 shares of Sensus Healthcare common stock. This figure reflects his position immediately following the 1,500-share open-market purchase disclosed in the Form 4 filing.

Does Eric Sachetta have any indirect ownership of Sensus Healthcare (SRTS) shares?

Yes. The Form 4 shows indirect ownership of 2,093 Sensus Healthcare common shares attributed to his spouse. These shares are reported separately from his 143,613 directly held shares, reflecting additional economic exposure to the company.

Was the Sensus Healthcare (SRTS) insider transaction a buy or sell?

The disclosed Sensus Healthcare insider transaction was a buy. Director Eric Sachetta executed an open-market purchase of 1,500 common shares at $3.335 per share, increasing his total directly held stake in the company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/12/2026 - 01:53 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sachetta Eric

(Last)

(First)

(Middle)

851 BROKEN SOUND PARKWAY NW #215

(Street)

BOCA RATON

FLORIDA

33487

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sensus Healthcare, Inc. [ SRTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/12/2026		P		1,500	A	$3.335	143,613	D
Common Stock								2,093	I	spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

	/s/ Eric Sachetta	05/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR